drugset / Trial / NCT06777732
The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study was to compare the efficacy of 14-day eradication of Helicobacter pylori with different doses of Keverprazan combined with Amoxicillin dual therapy and Keverprazan-based bismuth quadruple therapy and compare the adverse reactions, compliance, and factors affecting the efficacy of eradication schemes among different groups.
Timeline
- Start
- 2025-03
- Primary completion
- 2025-09
- Completion
- 2026-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1000 mg | — |
| Subject | Keverprazan | Unknown | 10 mg | — |
| Subject | Keverprazan | Unknown | 20 mg | — |
| Background | Furazolidone | Small molecule | 100 mg | — |
| Background | colloidal bismuth pectin | Unknown | 300 mg | — |